The breast reconstruction market encompasses diverse technologies, where surgical methods play a pivotal role. Inframammary reconstruction uses breast fold incisions for direct implant placement. Peri-areolar reconstruction involves incisions around the areola, while trans-axillary accesses the breast via armpit incisions. Transumbilical reconstruction utilizes navel-area incisions. These technologies cater to varied patient preferences, providing options for breast cancer survivors seeking personalized reconstructive surgery aligned with specific needs and desired outcomes, reflecting the evolving landscape of breast reconstruction techniques.
Access Full Report @ https://www.databridgemarketresearch.com/ko/reports/north-america-breast-reconstruction-market
Data Bridge Market Research analyses that the North America Breast Reconstruction Market which was USD 926.28 million in 2022, is expected to reach USD 1,805.42 million by 2030, at a CAGR of 8.7% during the forecast period 2023 to 2030. Increased health insurance coverage for breast reconstruction procedures removes financial barriers, making these surgeries more accessible. This expansion allows a wider spectrum of breast cancer survivors to choose reconstruction, improving their quality of life and recovery.
Key Findings of the Study
Patient advocacy is expected to drive the market's growth rate
Patient advocacy groups are integral in the breast reconstruction market, offering support and resources to mastectomy survivors. They empower individuals with information about reconstruction options, benefits, and choices. These groups foster community, providing emotional support and practical guidance. By ensuring patients are well-informed, advocacy groups contribute to informed decision-making, positively impacting the quality of life for those undergoing breast reconstruction after cancer.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
|
Market Players Covered
|
POLYTECH Health & Aesthetics GmbH (Germany), CEREPLAS (France), Guangzhou Wanhe Plastic Material Co., Ltd (China ), AbbVie Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), GC Aesthetics (U.K.), Laboratories Arion (France), Sientra Inc. (U.S.), HANSBIOMED CO. LTD (South Korea), Sientra, Inc. (U.S.), Deal Implant Incorporated (U.S), Integra LifeSciences (U.S.), PMT Corporation (U.S.), RTI Surgical (U.S.), Establishment Labs S.A. (U.S.), Silimed (Brazil)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The North America breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure and end user.
- On the basis of product, the North America breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix
- On the basis of type, the North America breast reconstruction market is segmented into unilateral, and bilateral
- On the basis of shape, the North America breast reconstruction market is segmented into round implants, and anatomical implants
- On the basis of technology, the North America breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical
- On the basis of placement, the North America breast reconstruction market is segmented into dual-plane insertion, subglandular insertion, and submuscular insertion
- On the basis of procedure, the North America breast reconstruction market is segmented into immediate procedures, delayed procedures, and revision procedures
- On the basis of end user, the North America breast reconstruction market is segmented into hospitals, cosmetology clinics, ambulatory surgical centers, and others
Major Players
Data Bridge Market Research recognizes the following companies as the major North America breast reconstruction market players in North America breast reconstruction market are Sientra, Inc. (U.S.), Deal Implant Incorporated (U.S), Integra LifeSciences (U.S.), PMT Corporation (U.S.), RTI Surgical (U.S.), Establishment Labs S.A. (U.S.), Silimed (Brazil)
Market Developments
- In 2022, Mentor Worldwide LLC, a Johnson & Johnson subsidiary, gained FDA approval for the MENTOR Memory Gel Enhanced breast implant. This new addition to Mentor's portfolio enhances breast augmentation options, showcasing the company's dedication to providing advanced and FDA-sanctioned solutions for breast reconstruction and enhancement
- In 2022, CollPlant started a study involving large animals for its 3D bioprinted regenerative breast implant program. Leveraging advanced 3D bioprinting, the initiative aims to meet specific requirements in breast reconstruction, potentially transforming the field by offering more natural and personalized options for patients
- In 2022, GC Aesthetics launched FixNip NRI, an Innovative Areola Complex (NAC) reconstruction implant. This implant addresses a global clinical need, providing a solution for breast cancer survivors and patients seeking post-mastectomy nipple-areola complex reconstruction. GC Aesthetics aims to enhance the quality of life and aesthetic outcomes for women
- In 2021, POLYTECH Health & Aesthetics received FDA approval for its textured breast implants, including macrotextured and polyurethane-coated varieties. This regulatory milestone allows the company to offer these implants in the US market, providing a broader range of patients with textured implants known for their natural feel and aesthetic results
- In 2020, Sientra achieved pre-market approval from the FDA for its OPUS-branded breast implant products. This regulatory milestone underscores Sientra's commitment to delivering high-quality and safe breast implant options in the U.S. market. With FDA approval, Sientra's OPUS implants became a trusted choice for breast augmentation and reconstruction, offering innovative solutions for aesthetic and restorative procedures
Regional Analysis
Geographically, the countries covered in the North America breast reconstruction market report are U.S., Canada and Mexico in North America.
As per Data Bridge Market Research analysis:
U.S. is the dominant region in North America breast reconstruction market during the forecast period 2023-2030
U.S. dominates the North America breast reconstruction market due to the escalating prevalence of breast cancer and the influential presence of key market players. The nation's strong healthcare infrastructure and significant advancements in surgical techniques propel the demand for breast reconstruction procedures. Moreover, the strong local presence of major industry players fosters accessibility. It ensures the availability of cutting-edge technologies, reinforcing the U.S. as a leader in the North American breast reconstruction market.
For more detailed information about the North America breast reconstruction market report, click here – https://www.databridgemarketresearch.com/ko/reports/north-america-breast-reconstruction-market
